Your Health, We Care
Release date: 2026-02-06 17:32:34 Article From: Lucius Laos Recommended: 8
Belzutifan produced by Lucius Pharmaceuticals is a bioequivalent generic drug with the same mechanism of action as the marketed drug. It is indicated for the treatment of diseases such as renal cell carcinoma and is generally more affordably priced.
Be sure to inform your doctor of any prescription or over-the-counter medicines, vitamins/minerals, herbal products and other supplements you are taking.
In particular, make sure to discuss whether you are using hormone-containing birth control pills, patches, vaginal rings, implants, injections or intrauterine devices.
Certain other medications may alter the blood concentration of Belzutifan, and vice versa. Please inform your doctor of all medications you are taking or have recently taken.
This may not be a complete list of medications that may interact with Lucius Pharmaceuticals' version of Belzutifan. Be sure to consult your doctor.
Currently, there are no known interactions between Lucius Pharmaceuticals' version of Belzutifan and food or beverages.
It is unknown whether alcohol consumption affects Belzutifan.
If you or someone else has taken an overdose of Belzutifan, seek medical help immediately and contact your doctor or pharmacist.
If you miss a dose, take it as soon as you remember on the same day. Then take your next dose at your usual time the following day. Do not take a double or extra dose.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：852025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3762024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：762025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：982025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：912025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：1072025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：1062025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：1022025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
